According to Insight Life's announcement, it recently received the “Medical Device Change Registration Document” issued by the State Drug Administration to complete changes in matters relating to the “Human SHOX2 and RASSF1A Gene Methylation DNA Test Kit” products. Meanwhile, the holding subsidiary Kanglu Biotech and the four medical device registration applications declared by the company were accepted by the State Drug Administration or the Shanghai Drug Administration, respectively. The registration of the above product changes and acceptance of registration applications is conducive to enriching the product line layout and improving competitiveness, but there is no impact on recent performance. Whether a registration certificate can be obtained is yet to be finally reviewed.

According to Insight Life's announcement, it recently received the “Medical Device Change Registration Document” issued by the State Drug Administration to complete changes in matters relating to the “Human SHOX2 and RASSF1A Gene Methylation DNA Test Kit” products. Meanwhile, the holding subsidiary Kanglu Biotech and the four medical device registration applications declared by the company were accepted by the State Drug Administration or the Shanghai Drug Administration, respectively. The registration of the above product changes and acceptance of registration applications is conducive to enriching the product line layout and improving competitiveness, but there is no impact on recent performance. Whether a registration certificate can be obtained is yet to be finally reviewed.